Final Report of a Phase III Randomized Trial of Amifostine as a Radioprotectant in Head and Neck Cancer

Todd Doyle, MD
OncoLink Assistant Editor
Ultima Vez Modificado: 1 de noviembre del 1999

Translation for this article does not exist